Market Research Reports.Biz announces addition of new report “ Pharmaceutical Market ” to its database.
The Iran, Egypt, Portugal, Kuwait, Peru pharmaceutical market remains a powerhouse in the Emerging Europe region . The country has by far the largest population in the region. I ts resource s -driven economic growth is funding both private and public spending on medicines and healthcare services. The country's World Trade Organisation (WTO) accession has eliminated tariff barriers and should, in the long run, drive major improvements in a problematic intellectual property environment.
Visit Same Publisher Report: The Pharmaceutical Market: Russia, Spain, United Kingdom, India, Finland
Both domestic and cross-border mergers and acquisitions (M&A) activity has picked up since the 2009 economic crisis, a result of increased incentives for local production under the government's industrial policy for the sector and the need for scale to compete , especially in the generic medicines market. We believe a critical forward step for the market will be the successful implementation of a broad-based medicines insurance programmer in the next few years, following current pilot projects. If this proves successful, we would expect growth to outstrip our current five-year projection for a compound annual growth rate of 8.3% in US dollar terms during the period 2012-2017.
For More Latest Reports Under the Same Category: Pharmaceutical Market
Headline Expenditure Projections
Pharmaceuticals: RUB664.72bn (US$20.96bn) in 2012 to RUR728.00bn (US$22.40bn) in 2013; +9.5% in local currency terms and 6.9% in US dollar terms. Forecast is virtually unchanged from Q412.
Healthcare: RUB2,709.62 (US$85.42bn) in 2012 to RUB2928.54bn (US$90.11bn) in 2013; +8.1% in local currency terms and +5.5% in US dollar terms. Forecast is virtually unchanged from Q412.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Executive Summary
SWOT Analysis
Iran, Egypt, Portugal, Kuwait, Peru Pharmaceuticals And Healthcare Industry SWOT
Iran, Egypt, Portugal, Kuwait, Peru Political SWOT
Iran, Egypt, Portugal, Kuwait, Peru Economic SWOT
Iran, Egypt, Portugal, Kuwait, Peru Business Environment SWOT
Pharmaceutical Risk/Reward Ratings
Table: CEE Pharmaceutical Risk/Reward Ratings, Q213
Competitive Landscape
Manufacturing Sector
Company Activity
Wholesale Sector
Retail Sector
Company Profiles
Berlin-Chemie/Menarini Pharma GmbH
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: +1-866-997-4948
Browse Market Research Blog:
Blog: Markets News
No comments:
Post a Comment